title: Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library.
abstract: To generate a stable resource from which high affinity human antibodies to any given antigen can be rapidly isolated, functional V-gene segments from 43 non-immunized human donors were used to construct a repertoire of 1.4 x 10(10) single-chain Fv (scFv) fragments displayed on the surface of phage. Fragments were cloned in a phagemid vector, enabling both phage displayed and soluble scFv to be produced without subcloning. A hexahistidine tag has been incorporated to allow rapid purification of scFv by nickel chelate chromatography. This library format reduces the time needed to isolate monoclonal antibody fragments to under two weeks. All of the measured binding affinities show a Kd < 10 nM and off-rates of 10(-3) to 10(-4) s-1, properties usually associated with antibodies from a secondary immune response. The best of these scFvs, an anti-fluorescein antibody (0.3 nM) and an antibody directed against the hapten DTPA (0.8 nM), are the first antibodies with subnanomolar binding affinities to be isolated from a naive library. Antibodies to doxorubicin, which is both immunosuppressive and toxic, as well as a high affinity and high specificity antibody to the steroid hormone oestradiol have been isolated. This work shows that conventional hybridoma technology may be superseded by large phage libraries that are proving to be a stable and reliable source of specific, high affinity human monoclonal antibodies.
authors.affiliation: Cambridge Antibody Technology Ltd., Unit B3, Melbourn, Cambridgeshire, U.K.
authors.forename: T J
authors.initials: TJ
authors.lastname: Vaughan
authors.forename: A J
authors.initials: AJ
authors.lastname: Williams
authors.forename: K
authors.initials: K
authors.lastname: Pritchard
authors.forename: J K
authors.initials: JK
authors.lastname: Osbourn
authors.forename: A R
authors.initials: AR
authors.lastname: Pope
authors.forename: J C
authors.initials: JC
authors.lastname: Earnshaw
authors.forename: J
authors.initials: J
authors.lastname: McCafferty
authors.forename: R A
authors.initials: RA
authors.lastname: Hodits
authors.forename: J
authors.initials: J
authors.lastname: Wilton
authors.forename: K S
authors.initials: KS
authors.lastname: Johnson
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000302:isolation & purification* / Q000378:metabolism; D000915:Antibody Affinity; D000918:Antibody Specificity; D001435:Bacteriophages / Q000235:genetics / Q000276:immunology; D001483:Base Sequence; D001709:Biotechnology; D003001:Cloning, Molecular; D004317:Doxorubicin / Q000276:immunology; D004958:Estradiol / Q000276:immunology; D006801:Humans; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D007128:Immunoglobulin Fragments; D009838:Oligodeoxyribonucleotides; C055966:immunoglobulin Fv; D004958:Estradiol; D004317:Doxorubicin